Sylogist Total Liab vs Short Term Debt Analysis

SYZ Stock

CAD 8.75 0.24 2.82%

Sylogist financial indicator trend analysis is much more than just breaking down Sylogist prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sylogist is a good investment. Please check the relationship between Sylogist Total Liab and its Short Term Debt accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sylogist. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Total Liab vs Short Term Debt

Total Liab vs Short Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sylogist Total Liab account and Short Term Debt. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Sylogist's Total Liab and Short Term Debt is 0.97. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of Sylogist, assuming nothing else is changed. The correlation between historical values of Sylogist's Total Liab and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Sylogist are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Total Liab i.e., Sylogist's Total Liab and Short Term Debt go up and down completely randomly.

Correlation Coefficient

0.97

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Short Term Debt

Most indicators from Sylogist's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sylogist current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sylogist. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Sylogist's Selling General Administrative is very stable compared to the past year. As of the 2nd of May 2025, Sales General And Administrative To Revenue is likely to grow to 0.31, though Tax Provision is likely to grow to (328.7 K).

	2022	2023	2024	2025 (projected)
Total Revenue	69M	65.5M	65.6M	68.9M
Depreciation And Amortization	12.9M	10.1M	11.7M	12.2M

Total Revenue Depreciation And Amortization

Sylogist fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Inventory	Intangible Assets	Current Deferred Revenue	Short Term Investments	Non Currrent Assets Other	Good Will
Total Assets		0.73	0.72	0.86	0.68	0.62	0.05	-0.84	0.62	0.39	0.9	0.37	0.68	0.6	0.73	0.91	-0.39	0.87	0.56	0.74	0.15	0.9	0.89	0.22	-0.46	0.85
Short Long Term Debt Total	0.73		0.62	0.92	0.02	0.75	0.7	-0.88	0.65	-0.3	0.94	-0.32	0.8	0.18	0.86	0.76	-0.19	0.97	-0.13	1.0	0.13	0.94	0.88	-0.05	-0.36	0.97
Other Current Liab	0.72	0.62		0.78	0.43	0.75	0.28	-0.61	0.68	0.01	0.77	-0.02	0.71	0.46	0.47	0.75	-0.28	0.72	0.23	0.61	0.09	0.75	0.6	0.33	-0.32	0.69
Total Current Liabilities	0.86	0.92	0.78		0.3	0.85	0.47	-0.91	0.63	-0.05	0.96	-0.07	0.8	0.39	0.72	0.83	-0.29	0.97	0.14	0.93	0.14	0.97	0.9	0.11	-0.5	0.95
Total Stockholder Equity	0.68	0.02	0.43	0.3		0.21	-0.66	-0.29	0.14	0.89	0.32	0.88	0.08	0.71	0.1	0.46	-0.36	0.25	0.97	0.04	0.08	0.32	0.34	0.5	-0.41	0.2
Property Plant And Equipment Net	0.62	0.75	0.75	0.85	0.21		0.44	-0.65	0.37	-0.12	0.75	-0.14	0.5	0.29	0.38	0.51	-0.21	0.73	0.03	0.74	0.03	0.76	0.57	0.12	-0.68	0.71
Net Debt	0.05	0.7	0.28	0.47	-0.66	0.44		-0.42	0.43	-0.89	0.48	-0.9	0.59	-0.3	0.53	0.27	0.15	0.52	-0.79	0.68	0.01	0.46	0.38	-0.28	0.04	0.56
Retained Earnings	-0.84	-0.88	-0.61	-0.91	-0.29	-0.65	-0.42		-0.6	0.01	-0.91	0.04	-0.84	-0.38	-0.8	-0.86	0.27	-0.93	-0.17	-0.88	-0.08	-0.92	-0.96	-0.09	0.39	-0.94
Accounts Payable	0.62	0.65	0.68	0.63	0.14	0.37	0.43	-0.6		-0.15	0.74	-0.19	0.82	0.03	0.77	0.84	-0.38	0.72	0.01	0.65	0.15	0.71	0.68	-0.17	0.07	0.73
Cash	0.39	-0.3	0.01	-0.05	0.89	-0.12	-0.89	0.01	-0.15		-0.04	0.99	-0.27	0.51	-0.15	0.13	-0.32	-0.09	0.96	-0.28	0.07	-0.02	0.05	0.32	-0.28	-0.14
Non Current Assets Total	0.9	0.94	0.77	0.96	0.32	0.75	0.48	-0.91	0.74	-0.04		-0.06	0.84	0.38	0.86	0.91	-0.3	0.99	0.15	0.95	0.14	1.0	0.94	0.07	-0.4	0.98
Cash And Short Term Investments	0.37	-0.32	-0.02	-0.07	0.88	-0.14	-0.9	0.04	-0.19	0.99	-0.06		-0.29	0.52	-0.17	0.1	-0.26	-0.11	0.96	-0.3	0.05	-0.05	0.03	0.32	-0.26	-0.16
Net Receivables	0.68	0.8	0.71	0.8	0.08	0.5	0.59	-0.84	0.82	-0.27	0.84	-0.29		0.26	0.79	0.89	-0.13	0.86	-0.06	0.8	0.07	0.82	0.85	0.0	-0.05	0.88
Common Stock Shares Outstanding	0.6	0.18	0.46	0.39	0.71	0.29	-0.3	-0.38	0.03	0.51	0.38	0.52	0.26		0.16	0.43	0.1	0.33	0.65	0.19	0.11	0.37	0.39	0.79	-0.38	0.29
Non Current Liabilities Total	0.73	0.86	0.47	0.72	0.1	0.38	0.53	-0.8	0.77	-0.15	0.86	-0.17	0.79	0.16		0.83	-0.22	0.88	-0.02	0.86	0.13	0.85	0.88	-0.12	-0.06	0.89
Other Current Assets	0.91	0.76	0.75	0.83	0.46	0.51	0.27	-0.86	0.84	0.13	0.91	0.1	0.89	0.43	0.83		-0.31	0.89	0.32	0.77	0.07	0.89	0.91	0.08	-0.21	0.89
Other Stockholder Equity	-0.39	-0.19	-0.28	-0.29	-0.36	-0.21	0.15	0.27	-0.38	-0.32	-0.3	-0.26	-0.13	0.1	-0.22	-0.31		-0.28	-0.32	-0.2	-0.63	-0.32	-0.29	0.14	0.17	-0.25
Total Liab	0.87	0.97	0.72	0.97	0.25	0.73	0.52	-0.93	0.72	-0.09	0.99	-0.11	0.86	0.33	0.88	0.89	-0.28		0.09	0.97	0.15	0.99	0.96	0.03	-0.37	1.0
Total Current Assets	0.56	-0.13	0.23	0.14	0.97	0.03	-0.79	-0.17	0.01	0.96	0.15	0.96	-0.06	0.65	-0.02	0.32	-0.32	0.09		-0.11	0.07	0.16	0.23	0.45	-0.32	0.05
Short Term Debt	0.74	1.0	0.61	0.93	0.04	0.74	0.68	-0.88	0.65	-0.28	0.95	-0.3	0.8	0.19	0.86	0.77	-0.2	0.97	-0.11		0.15	0.95	0.9	-0.05	-0.36	0.97
Inventory	0.15	0.13	0.09	0.14	0.08	0.03	0.01	-0.08	0.15	0.07	0.14	0.05	0.07	0.11	0.13	0.07	-0.63	0.15	0.07	0.15		0.13	0.16	0.13	0.09	0.11
Intangible Assets	0.9	0.94	0.75	0.97	0.32	0.76	0.46	-0.92	0.71	-0.02	1.0	-0.05	0.82	0.37	0.85	0.89	-0.32	0.99	0.16	0.95	0.13		0.94	0.06	-0.44	0.98
Current Deferred Revenue	0.89	0.88	0.6	0.9	0.34	0.57	0.38	-0.96	0.68	0.05	0.94	0.03	0.85	0.39	0.88	0.91	-0.29	0.96	0.23	0.9	0.16	0.94		0.06	-0.29	0.96
Short Term Investments	0.22	-0.05	0.33	0.11	0.5	0.12	-0.28	-0.09	-0.17	0.32	0.07	0.32	0.0	0.79	-0.12	0.08	0.14	0.03	0.45	-0.05	0.13	0.06	0.06		-0.23	0.0
Non Currrent Assets Other	-0.46	-0.36	-0.32	-0.5	-0.41	-0.68	0.04	0.39	0.07	-0.28	-0.4	-0.26	-0.05	-0.38	-0.06	-0.21	0.17	-0.37	-0.32	-0.36	0.09	-0.44	-0.29	-0.23		-0.32
Good Will	0.85	0.97	0.69	0.95	0.2	0.71	0.56	-0.94	0.73	-0.14	0.98	-0.16	0.88	0.29	0.89	0.89	-0.25	1.0	0.05	0.97	0.11	0.98	0.96	0.0	-0.32

Click cells to compare fundamentals

Sylogist Account Relationship Matchups

Sylogist fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	71.0M	98.0M	103.1M	96.6M	97.9M	102.8M
Other Current Liab	2.2M	3.2M	5.6M	6.4M	3.9M	2.0M
Total Current Liabilities	16.6M	39.8M	50.9M	48.7M	34.3M	36.0M
Total Stockholder Equity	51.9M	46.7M	39.9M	37.6M	37.6M	26.9M
Property Plant And Equipment Net	573K	1.6M	1.7M	1.4M	512K	492.0K
Net Debt	(42.3M)	(10.6M)	7.4M	6.1M	5.9M	6.2M
Retained Earnings	(31.7M)	(40.1M)	(50.0M)	(50.7M)	(53.3M)	(50.6M)
Accounts Payable	372K	630K	1.6M	1.9M	2.1M	2.2M
Cash	42.8M	29.6M	14.5M	11.6M	13.3M	17.2M
Non Current Assets Total	22.8M	64.5M	75.6M	70.3M	70.2M	73.8M
Cash And Short Term Investments	42.8M	29.6M	14.5M	11.6M	13.3M	18.3M
Net Receivables	3.5M	2.0M	9.4M	10.9M	9.7M	10.2M
Common Stock Shares Outstanding	23.8M	24.1M	23.9M	23.7M	23.4M	18.1M
Liabilities And Stockholders Equity	71.0M	98.0M	103.1M	96.6M	111.1M	116.6M
Non Current Liabilities Total	2.4M	11.6M	12.2M	10.3M	26.0M	27.3M
Other Stockholder Equity	3.3M	4.5M	5.5M	5.8M	5.2M	6.3M
Total Liab	19.1M	51.3M	63.2M	59.0M	60.3M	63.3M
Total Current Assets	48.1M	33.6M	27.5M	26.3M	27.7M	22.2M
Short Term Debt	380K	18.5M	21.5M	17.5M	20.1M	21.1M
Accumulated Other Comprehensive Income	722K	(32K)	2.2M	1.5M	1.8M	1.9M
Inventory	267K	218K	211K	248K	285.2K	225.6K
Intangible Assets	14.1M	41.6M	47.4M	42.7M	42.4M	44.5M
Current Deferred Revenue	13.7M	17.5M	22.2M	22.9M	26.3M	27.7M
Non Currrent Assets Other	(22.8M)	(64.5M)	(75.6M)	(1.0)	(0.9)	(0.94)
Good Will	8.2M	21.3M	26.5M	26.2M	27.4M	28.7M
Common Stock	79.6M	82.4M	82.2M	81.0M	93.2M	72.0M
Capital Surpluse	2.4M	3.3M	4.5M	5.5M	4.9M	4.7M
Property Plant Equipment	141K	573K	1.6M	1.8M	2.0M	2.1M
Other Liab	2.4M	2.3M	11.0M	13.8M	15.8M	16.6M
Net Tangible Assets	37.0M	29.6M	(16.2M)	(38.6M)	(34.8M)	(33.0M)
Net Invested Capital	58.5M	51.9M	64.9M	54.8M	56.7M	58.3M
Net Working Capital	39.2M	31.5M	(6.2M)	(22.4M)	(6.6M)	(6.3M)

Pair Trading with Sylogist

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sylogist position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sylogist will appreciate offsetting losses from the drop in the long position's value.

Moving against Sylogist Stock

0.83	LABS	Medipharm Labs Corp	Pair Corr
0.76	CU	Canadian Utilities	Pair Corr
0.73	KNT	K92 Mining	Pair Corr
0.73	CVS	CVS HEALTH CDR	Pair Corr
0.73	GAL	Galantas Gold Corp	Pair Corr

The ability to find closely correlated positions to Sylogist could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sylogist when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sylogist - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sylogist to buy it.

The correlation of Sylogist is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sylogist moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sylogist moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Sylogist can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Other Information on Investing in Sylogist Stock

Balance Sheet is a snapshot of the financial position of Sylogist at a specified time, usually calculated after every quarter, six months, or one year. Sylogist Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Sylogist and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Sylogist currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sylogist Total Liab vs Short Term Debt Analysis

Total Liab vs Short Term Debt

Total Liab vs Short Term Debt Correlation Analysis

Correlation Coefficient

Total Liab

Short Term Debt

Sylogist fundamental ratios Correlations

Sylogist Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Sylogist fundamental ratios Accounts

Pair Trading with Sylogist

Moving against Sylogist Stock

Other Information on Investing in Sylogist Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Short Term Debt	+ 1.0	Short Long Term Debt Total
Intangible Assets	+ 1.0	Non Current Assets Total
Good Will	+ 1.0	Total Liab
Cash And Short Term Investments	+ 0.99	Cash
Total Liab	+ 0.99	Non Current Assets Total
Intangible Assets	+ 0.99	Total Liab

Current Deferred Revenue	- 0.96	Retained Earnings
Good Will	- 0.94	Retained Earnings
Total Liab	- 0.93	Retained Earnings
Intangible Assets	- 0.92	Retained Earnings
Non Current Assets Total	- 0.91	Retained Earnings
Retained Earnings	- 0.91	Total Current Liabilities